Patient blood management in pediatric cardiac surgery: A review

Anesthesia and Analgesia

Volumn 127, Issue 4, 2018, Pages 1002-1016

  Cholette, Jill M ^a   Faraoni, David ^b   Goobie, Susan M ^c,d   Ferraris, Victor ^e   Hassan, Nabil ^f  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c Perioperative and Pain Medicine ^*  (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^f UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; HEMOGLOBIN; HEMOSTATIC AGENT; ANTIANEMIC AGENT; COAGULATING AGENT;

ANEMIA; ANTICOAGULANT THERAPY; ANTICOAGULATION; ASSISTED CIRCULATION; BLOOD CLOTTING DISORDER; BLOOD CONSERVATION; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CRITICALLY ILL PATIENT; HEART SURGERY; HEMOCONCENTRATION; HEMODILUTION; HUMAN; HYPOTHERMIA; INFLAMMATION; PEDIATRIC SURGERY; PERIOPERATIVE PERIOD; POINT OF CARE TESTING; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; VULNERABLE POPULATION; ADOLESCENT; AGE; BLOOD; BLOOD TRANSFUSION REACTION; CHILD; COMPLICATION; DRUG EFFECT; HEMOSTASIS; INFANT; NEWBORN; OPERATIVE BLOOD LOSS; PRESCHOOL CHILD; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; ANEMIA; ANTICOAGULANTS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; COAGULANTS; HEMATINICS; HEMODILUTION; HEMOSTASIS; HUMANS; INFANT; INFANT, NEWBORN; PERIOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; RISK ASSESSMENT; RISK FACTORS; TRANSFUSION REACTION; TREATMENT OUTCOME;

EID: 85060337002     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000002504     Document Type: Review

References (167)

1. Osthaus WA, Boethig D, Johanning K, et al. Whole blood coagulation measured by modified thrombelastography (ROTEM) is impaired in infants with congenital heart diseases. Blood Coagul Fibrinolysis. 2008;19:220-225.
2. Guzzetta NA. Benefits and risks of red blood cell transfusion in pediatric patients undergoing cardiac surgery. Paediatr Anaesth. 2011;21:504-511.
3. Armano R, Gauvin F, Ducruet T, Lacroix J. Determinants of red blood cell transfusions in a pediatric critical care unit: a prospective, descriptive epidemiological study. Crit Care Med. 2005;33:2637-2644.
4. DiNardo JA. Blood transfusions might be bad for you; that is unless you are bleeding. Anesth Analg. 2013;116:1201-1203.
5. Kipps AK, Wypij D, Thiagarajan RR, Bacha EA, Newburger JW. Blood transfusion is associated with prolonged duration of mechanical ventilation in infants undergoing reparative cardiac surgery. Pediatr Crit Care Med. 2011;12:52-56.
6. Iyengar A, Scipione CN, Sheth P, et al. Association of complications with blood transfusions in pediatric cardiac surgery patients. Ann Thorac Surg. 2013;96:910-916.
7. Redlin M, Kukucka M, Boettcher W, et al. Blood transfusion determines postoperative morbidity in pediatric cardiac surgery applying a comprehensive blood-sparing approach. J Thorac Cardiovasc Surg. 2013;146:537-542.
8. Shander A, Bracey AW Jr, Goodnough LT, et al. Patient blood management as standard of care. Anesth Analg. 2016;123:1051-1053.
9. Goobie SM, Haas T. Perioperative bleeding management in pediatric surgery. Curr Opin Anaesthesiol. 2016;29:352-358.
10. Hassan N, Halanski M, Wincek J, et al. Blood management in pediatric spinal deformity surgery: review of a 2-year experience. Transfusion. 2011;51:2133-2141.
11. Hassan N, Rajasekaran S. Special perioperative management: pediatric and neonatal patients. In: Waters JH, Frank SM, eds. Text Book of Patient Blood Management: Multidisciplinary Approaches of optimizing Care. Bethesda, MD: AABB Press; 2016.
12. Mohanty S, Vaidyanathan B. Anti-platelet agents in pediatric cardiac practice. Ann Pediatr Cardiol. 2013;6:59-64.
13. Myles PS, Smith JA, Forbes A, et al; ATACAS Investigators of the ANZCA Clinical Trials Network. Stopping vs continuing aspirin before coronary artery surgery. N Engl J Med. 2016;374:728-737.
14. Oscarsson A, Gupta A, Fredrikson M, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth. 2010;104:305-312.
15. Hastings S, Myles P, McIlroy D. Aspirin and coronary artery surgery: a systematic review and meta-analysis. Br J Anaesth. 2015;115:376-385.
16. Nguyen N, Sharathkumar A. Current perioperative anticoagulation practices in children with prosthetic mechanical heart valves. Congenit Heart Dis. 2015;10:E210-E215.
17. Campbell S, Monagle P, Newall F. Oral anticoagulant therapy interruption in children: a single centre experience. Thromb Res. 2016;140:89-93.
18. Monagle P, Chan AKC, Goldenberg NA, et al. Antithrombotic therapy in infants and children: antithrombotic therapy and prevention of thrombosis, 9th Ed: American College of Chest Physicians Evidence-based clinical practice guidelines. Chest. 2012; 141:737S-801S.
19. Chakravarthy M. Modifying risks to improve outcome in cardiac surgery: an anesthesiologist's perspective. Ann Card Anaesth. 2017;20:226-233.
20. Karkouti K, Wijeysundera DN, Beattie WS; Reducing Bleeding in Cardiac Surgery (RBC) Investigators. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation. 2008;117:478-484.
21. van Straten AH, Hamad MA, van Zundert AJ, Martens EJ, Schönberger JP, de Wolf AM. Preoperative hemoglobin level as a predictor of survival after coronary artery bypass grafting: a comparison with the matched general population. Circulation. 2009;120:118-125.
22. Klein AA, Collier TJ, Brar MS, et al; Association of Cardiothoracic Anaesthetists (ACTA). The incidence and importance of anaemia in patients undergoing cardiac surgery in the UK - the first Association of Cardiothoracic Anaesthetists national audit. Anaesthesia. 2016;71:627-635.
23. Khan Z, Natarajan G, Sallaam S, et al. Association between anemia and packed cell transfusion and outcomes of ventricular septal defect and atrioventricular canal repair in children. Pediatr Cardiol. 2014;35:471-478.
24. Goobie SM, Faraoni D, Zurakowski D, DiNardo JA. Association of preoperative anemia with postoperative mortality in neonates. JAMA Pediatr. 2016;170:855-862.
25. Faraoni D, DiNardo JA, Goobie SM. Relationship between preoperative anemia and in-hospital mortality in children undergoing noncardiac surgery. Anesth Analg. 2016;123:1582-1587.
26. Hassan N, Boville B, Reischmann D, Ndika A, Sterken D, Kovey K. Intravenous ferumoxytol in pediatric patients with iron deficiency anemia: a single-center experience. Ann Pharmacother. 2017. doi: 10.1177/1060028017699429.
27. Shimpo H, Mizumoto T, Onoda K, Yuasa H, Yada I. Erythropoietin in pediatric cardiac surgery: clinical efficacy and effective dose. Chest. 1997;111:1565-1570.
28. Rajasekaran S, Halanski M, Cassidy JC, et al. Preoperative detection of low von Willebrand activity and operative blood loss in pediatric scoliosis patients undergoing posterior spinal fusion. J Pediatr Neonatal Care. 2017;6: 00230.
29. Arslan MT, Ozyurek R, Kavakli K, et al. Frequency of acquired von Willebrand's disease in children with congenital heart disease. Acta Cardiol. 2007;62:403-408.
30. Gossai N, Brown NM, Ameduri R, Zantek ND, Louis JS, Steiner ME. Pediatric acquired von Willebrand disease with Berlin Heart Excor ventricular assist device support. World J Pediatr Congenit Heart Surg. 2016;7:614-618.
31. Shander A, Kaplan LJ, Harris MT, et al. Topical hemostatic therapy in surgery: bridging the knowledge and practice gap. J Am Coll Surg. 2014;219:570-9.e4.
32. Neptune WB, Bougas JA, Panico FG. Open-heart surgery without the need for donor-blood priming in the pump oxygenator. N Engl J Med. 1960;263:111-115.
33. Cooper JR Jr. Perioperative considerations in Jehovah's Witnesses. Int Anesthesiol Clin. 1990;28:210-215.
34. Newman MF, Kirchner JL, Phillips-Bute B, et al; Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001;344:395-402.
35. Shin'oka T, Shum-Tim D, Jonas RA, et al. Higher hematocrit improves cerebral outcome after deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 1996;112:1610-1620.
36. Elliott M, Rao PV, Hampton M. Current paediatric perfusion practice in the UK. Perfusion. 1993;8:7-25.
37. De Somer F, Foubert L, Poelaert J, Dujardin D, Van Nooten G, François K. Low extracorporeal priming volumes for infants: a benefit? Perfusion. 1996;11:455-460.
38. Draaisma AM, Hazekamp MG, Frank M, Anes N, Schoof PH, Huysmans HA. Modified ultrafiltration after cardiopulmonary bypass in pediatric cardiac surgery. Ann Thorac Surg. 1997;64:521-525.
39. Jonas RA, Wypij D, Roth SJ, et al. The influence of hemodilution on outcome after hypothermic cardiopulmonary bypass: results of a randomized trial in infants. J Thorac Cardiovasc Surg. 2003;126:1765-1774.
40. Newburger JW, Jonas RA, Soul J, et al. Randomized trial of hematocrit 25% versus 35% during hypothermic cardiopulmonary bypass in infant heart surgery. J Thorac Cardiovasc Surg. 2008;135:347-54, 354.e1.
41. Wypij D, Jonas RA, Bellinger DC, et al. The effect of hematocrit during hypothermic cardiopulmonary bypass in infant heart surgery: results from the combined Boston hematocrit trials. J Thorac Cardiovasc Surg. 2008;135:355-360.
42. Naguib AN, Winch PD, Tobias JD, et al. A single-center strategy to minimize blood transfusion in neonates and children undergoing cardiac surgery. Paediatr Anaesth. 2015;25:477-486.
43. Budak AB, McCusker K, Gunaydin S. A structured blood conservation program in pediatric cardiac surgery. Eur Rev Med Pharmacol Sci. 2017;21:1074-1079.
44. Karimi M, Florentino-Pineda I, Weatherred T, et al. Blood conservation operations in pediatric cardiac patients: a paradigm shift of blood use. Ann Thorac Surg. 2013;95:962-967.
45. DiNardo JA, Faraoni D. Red blood cell transfusion and massive bleeding in children undergoing heart transplant. Anesth Analg. 2016;122:1245-1246.
46. Willems A, Van Lerberghe C, Gonsette K, et al. The indication for perioperative red blood cell transfusions is a predictive risk factor for severe postoperative morbidity and mortality in children undergoing cardiac surgery. Eur J Cardiothorac Surg. 2014;45:1050-1057.
47. Richmond ME, Charette K, Chen JM, Quaegebeur JM, Bacha E. The effect of cardiopulmonary bypass prime volume on the need for blood transfusion after pediatric cardiac surgery. J Thorac Cardiovasc Surg. 2013;145:1058-1064.
48. Redlin M, Huebler M, Boettcher W, et al. Minimizing intraoperative hemodilution by use of a very low priming volume cardiopulmonary bypass in neonates with transposition of the great arteries. J Thorac Cardiovasc Surg. 2011;142:875-881.
49. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983;86:845-857.
50. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest. 1997;112:676-692.
51. Ando M, Takahashi Y, Suzuki N. Open heart surgery for small children without homologous blood transfusion by using remote pump head system. Ann Thorac Surg. 2004;78:1717-1722.
52. Miyaji K, Kohira S, Miyamoto T, et al. Pediatric cardiac surgery without homologous blood transfusion, using a miniaturized bypass system in infants with lower body weight. J Thorac Cardiovasc Surg. 2007;134:284-289.
53. Karimi M, Sullivan JM, Linthicum C, Mathew A. Blood conservation pediatric cardiac surgery in all ages and complexity levels. World J Cardiol. 2017;9:332-338.
54. Thompson LD, McElhinney DB, Findlay P, et al. A prospective randomized study comparing volume-standardized modified and conventional ultrafiltration in pediatric cardiac surgery. J Thorac Cardiovasc Surg. 2001;122:220-228.
55. Golab HD, Kissler J, de Jong PL, van de Woestijne PC, Takkenberg JJ, Bogers AJ. Clinical outcome and blood transfusion after infant cardiac surgery with a routine use of conventional ultrafiltration. Perfusion. 2015;30:323-331.
56. Kuranti N, Busangjaroen P, Srimueang T, et al. Modified versus conventional ultrafiltration in pediatric cardiac surgery: a meta-analysis of randomized controlled trials comparing clinical outcome parameters. J Thorac Cardiovasc Surg. 2011;142:861-867.
57. Durandy Y. Usefulness of low prime perfusion pediatric circuit in decreasing blood transfusion. ASAIO J. 2007;53:659-661.
58. Redlin M, Habazettl H, Boettcher W, et al. Effects of a comprehensive blood-sparing approach using body weight-adjusted miniaturized cardiopulmonary bypass circuits on transfusion requirements in pediatric cardiac surgery. J Thorac Cardiovasc Surg. 2012;144:493-499.
59. Merkle F, Boettcher W, Schulz F, Koster A, Huebler M, Hetzer R. Perfusion technique for nonhaemic cardiopulmonary bypass prime in neonates and infants under 6 kg body weight. Perfusion. 2004;19:229-237.
60. Petäjä J, Lundström U, Leijala M, Peltola K, Siimes MA. Bleeding and use of blood products after heart operations in infants. J Thorac Cardiovasc Surg. 1995;109:524-529.
61. Manno CS, Hedberg KW, Kim HC, et al. Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children. Blood. 1991;77:930-936.
62. Mou SS, Giroir BP, Molitor-Kirsch EA, et al. Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants. N Engl J Med. 2004;351:1635-1644.
63. Valleley MS, Buckley KW, Hayes KM, Fortuna RR, Geiss DM, Holt DW. Are there benefits to a fresh whole blood vs packed red blood cell cardiopulmonary bypass prime on outcomes in neonatal and pediatric cardiac surgery? J Extra Corpor Technol. 2007;39:168-176.
64. Gruenwald CE, McCrindle BW, Crawford-Lean L, et al. Reconstituted fresh whole blood improves clinical outcomes compared with stored component blood therapy for neonates undergoing cardiopulmonary bypass for cardiac surgery: a randomized controlled trial. J Thorac Cardiovasc Surg. 2008;136:1442-1449.
65. Jobes DR, Sesok-Pizzini D, Friedman D. Reduced transfusion requirement with use of fresh whole blood in pediatric cardiac surgical procedures. Ann Thorac Surg. 2015;99:1706-1711.
66. Durandy Y. Use of blood products in pediatric cardiac surgery. Artif Organs. 2015;39:21-27.
67. Jong WL, Young-Chul Y, Han Ki P, Sou-Ouk B, Ki-Young L, Sun-Joon B. Fresh frozen plasma in pump priming for congenital heart surgery: evaluation of effects on postoperative coagulation profiles using a fibrinogen assay and rotational thromboelastometry. Yonsei Med J. 2013;54:752-756.
68. Faraoni D, Van der Linden P. Factors affecting postoperative blood loss in children undergoing cardiac surgery. J Cardiothorac Surg. 2014;9:32.
69. Desborough M, Sandu R, Brunskill SJ, et al. Fresh frozen plasma for cardiovascular surgery. Cochrane Database Syst Rev. 2015;7:CD007614.
70. Baumgartner WA, Owens SG, Cameron DE, Reitz BA. The Johns Hopkins Manual of Cardiac Surgical Care. St Louis, MO: Mosby; 1994.
71. Luehr M, Bachet J, Mohr FW, Etz CD. Modern temperature management in aortic arch surgery: the dilemma of moderate hypothermia. Eur J Cardiothorac Surg. 2014;45:27-39.
72. Weidman JL, Shook DC, Hilberath JN. Cardiac resuscitation and coagulation. Anesthesiology. 2014;120:1009-1014.
73. Xiong Y, Sun Y, Ji B, Liu J, Wang G, Zheng Z. Systematic review and meta-analysis of benefits and risks between normothermia and hypothermia during cardiopulmonary bypass in pediatric cardiac surgery. Paediatr Anaesth. 2015;25:135-142.
74. DiNardo JA. Normothermic CPB for pediatric cardiac surgery, not ready for prime time. Paediatr Anaesth. 2015;25:111-112.
75. Singh SP. Strategies for blood conservation in pediatric cardiac surgery. Ann Card Anaesth. 2016;19:705-716.
76. Dahmani S, Orliaguet GA, Meyer PG, Blanot S, Renier D, Carli PA. Perioperative blood salvage during surgical correction of craniosynostosis in infants. Br J Anaesth. 2000;85:550-555.
77. Orliaguet GA, Bruyere M, Meyer PG, Blanot S, Renier D, Carli PA. Comparison of perioperative blood salvage and postoperative reinfusion of drained blood during surgical correction of craniosynostosis in infants. Paediatr Anaesth. 2003;13:797-804.
78. Kwak JG, Park M, Lee J, Lee CH. Multiple approaches to minimize transfusions for pediatric patients in open-heart surgery. Pediatr Cardiol. 2016;37:44-49.
79. Despotis GJ, Gravlee G, Filos K, Levy J. Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology. 1999;91:1122-1151.
80. De Somer F, Van Belleghem Y, Caes F, et al. Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2002;123:951-958.
81. Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med. 2004;30:1873-1881.
82. Levy JH, Tanaka KA. Anticoagulation and reversal paradigms: is too much of a good thing bad? Anesth Analg. 2009;108:692-694.
83. Gravlee GP. Anticoagulation for cardiopulmonary bypass. In Gravlee GP, Davis RE, Utley JR, eds. Cardiopulmonary Bypass. Principles and Practice. Baltimore, MD: Williams & Wilkins, 1993:340-380.
84. Guzzetta NA, Monitz HG, Fernandez JD, Fazlollah TM, Knezevic A, Miller BE. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass. Anesth Analg. 2010;111:173-179.
85. Martindale SJ, Shayevitz JR, D'Errico C. The activated coagulation time: suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery. J Cardiothorac Vasc Anesth. 1996;10:458-463.
86. Raymond PD, Ray MJ, Callen SN, Marsh NA. Heparin monitoring during cardiac surgery. Part 1: validation of whole-blood heparin concentration and activated clotting time. Perfusion. 2003;18:269-276.
87. Codispoti M, Ludlam CA, Simpson D, Mankad PS. Individualized heparin and protamine management in infants and children undergoing cardiac operations. Ann Thorac Surg. 2001;71:922-927.
88. Gruenwald CE, Manlhiot C, Chan AK, et al. Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass. J Am Coll Cardiol. 2010;56:1794-1802.
89. D'Errico C, Shayevitz JR, Martindale SJ. Age-related differences in heparin sensitivity and heparin-protamine interactions in cardiac surgery patients. J Cardiothorac Vasc Anesth. 1996;10:451-457.
90. Gautam NK, Schmitz ML, Harrison D, et al. Impact of protamine dose on activated clotting time and thromboelastography in infants and small children undergoing cardiopulmonary bypass. Paediatr Anaesth. 2013;23:233-241.
91. Willems A, Savan V, Faraoni D, et al. Heparin reversal after cardiopulmonary bypass: are point-of-care coagulation tests interchangeable? J Cardiothorac Vasc Anesth. 2016;30:1184-1189.
92. Mojcik CF, Levy JH. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg. 2001;71:745-754.
93. Koster A, Faraoni D, Levy JH. Antifibrinolytic therapy for cardiac surgery: an update. Anesthesiology. 2015;123:214-221.
94. Schouten ES, van de Pol AC, Schouten AN, Turner NM, Jansen NJ, Bollen CW. The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis. Pediatr Crit Care Med. 2009;10:182-190.
95. Pasquali SK, Hall M, Li JS, et al. Safety of aprotinin in congenital heart operations: results from a large multicenter database. Ann Thorac Surg. 2010;90:14-21.
96. Faraoni D, Goobie SM. New insights about the use of tranexamic acid in children undergoing cardiac surgery: from pharmacokinetics to pharmacodynamics. Anesth Analg. 2013;117:760-762.
97. Faraoni D, Willems A, Melot C, De Hert S, Van der Linden P. Efficacy of tranexamic acid in paediatric cardiac surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2012;42:781-786.
98. Martin K, Breuer T, Gertler R, et al. Tranexamic acid versus ϵ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. Eur J Cardiothorac Surg. 2011;39:892-897.
99. Faraoni D, Rozen L, Willems A, et al. Experimental model of hyperfibrinolysis designed for rotational thromboelastometry in children with congenital heart disease. Blood Coagul Fibrinolysis. 2015;26:290-297.
100. Yee BE, Wissler RN, Zanghi CN, Feng C, Eaton MP. The effective concentration of tranexamic acid for inhibition of fibrinolysis in neonatal plasma in vitro. Anesth Analg. 2013;117:767-772.
101. Rozen L, Faraoni D, Sanchez Torres C, et al. Effective tranexamic acid concentration for 95% inhibition of tissuetype plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: a prospective, controlled, in-vitro study. Eur J Anaesthesiol. 2015;32:844-850.
102. Soslau G, Horrow J, Brodsky I. Effect of tranexamic acid on platelet ADP during extracorporeal circulation. Am J Hematol. 1991;38:113-119.
103. Grassin-Delyle S, Couturier R, Abe E, Alvarez JC, Devillier P, Urien S. A practical tranexamic acid dosing scheme based on population pharmacokinetics in children undergoing cardiac surgery. Anesthesiology. 2013;118:853-862.
104. Wesley MC, Pereira LM, Scharp LA, Emani SM, McGowan FX Jr, DiNardo JA. Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. Anesthesiology. 2015;122:746-758.
105. Andersson L, Nilsoon IM, Colleen S, Granstrand B, Melander B. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA. Ann N Y Acad Sci. 1968;146:642-658.
106. Sigaut S, Tremey B, Ouattara A, et al. Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Anesthesiology. 2014;120:590-600.
107. Karski JM, Dowd NP, Joiner R, et al. The effect of three different doses of tranexamic acid on blood loss after cardiac surgery with mild systemic hypothermia (32 degrees C). J Cardiothorac Vasc Anesth. 1998;12:642-646.
108. Segal JB, Dzik WH; Transfusion Medicine/Hemostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion. 2005;45:1413-1425.
109. Perez-Ferrer A, Vicente-Sanchez J, Carceles-Baron MD, Van der Linden P, Faraoni D. Early thromboelastometry variables predict maximum clot firmness in children undergoing cardiac and non-cardiac surgery. Br J Anaesth. 2015;115:896-902.
110. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013;30:270-382.
111. American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology. 2015;122:241-275.
112. Karkouti K, McCluskey SA, Callum J, et al. Evaluation of a novel transfusion algorithm employing point-of-care coagulation assays in cardiac surgery: a retrospective cohort study with interrupted time-series analysis. Anesthesiology. 2015;122:560-570.
113. Pearse BL, Smith I, Faulke D, et al. Protocol guided bleeding management improves cardiac surgery patient outcomes. Vox Sang. 2015;109:267-279.
114. Miller BE, Guzzetta NA, Tosone SR, Levy JH. Rapid evaluation of coagulopathies after cardiopulmonary bypass in children using modified thromboelastography. Anesth Analg. 2000;90:1324-1330.
115. Romlin BS, Wåhlander H, Berggren H, et al. Intraoperative thromboelastometry is associated with reduced transfusion prevalence in pediatric cardiac surgery. Anesth Analg. 2011;112:30-36.
116. Faraoni D, Willems A, Savan V, Demanet H, De Ville A, Van der Linden P. Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. Eur J Anaesthesiol. 2014;31:317-326.
117. Faraoni D, Willems A, Romlin BS, Belisle S, Van der Linden P. Development of a specific algorithm to guide haemostatic therapy in children undergoing cardiac surgery: a single-centre retrospective study. Eur J Anaesthesiol. 2015;32:320-329.
118. Nakayama Y, Nakajima Y, Tanaka KA, et al. Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. Br J Anaesth. 2015;114:91-102.
119. Rahe-Meyer N, Solomon C, Hanke A, et al. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology. 2013;118:40-50.
120. Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A; Surgical Clinical Outcome REsearch (SCORE) Group. Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. J Am Heart Assoc. 2015;4:e002066.
121. Rahe-Meyer N, Levy JH, Mazer CD, et al. Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy. Br J Anaesth. 2016;117:41-51.
122. Galas FR, de Almeida JP, Fukushima JT, et al. Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. J Thorac Cardiovasc Surg. 2014;148:1647-1655.
123. Guzzetta NA, Russell IA, Williams GD. Review of the offlabel use of recombinant activated factor VII in pediatric cardiac surgery patients. Anesth Analg. 2012;115:364-378.
124. Downey L, Brown ML, Faraoni D, Zurakowski D, DiNardo JA. Recombinant factor VIIa is associated with increased thrombotic complications in pediatric cardiac surgery patients. Anesth Analg. 2017;124:1431-1436.
125. Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med. 2010;363:1791-1800.
126. Manlhiot C, Menjak IB, Brandão LR, et al. Risk, clinical features, and outcomes of thrombosis associated with pediatric cardiac surgery. Circulation. 2011;124:1511-1519.
127. Silvey M, Brandão LR. Risk factors, prophylaxis, and treatment of venous thromboembolism in congenital heart disease patients. Front Pediatr. 2017;5:146.
128. Manlhiot C, Brandão LR, Schwartz SM, et al. Management and outcomes of patients with occlusive thrombosis after pediatric cardiac surgery. J Pediatr. 2016;169:146-153.
129. Firdouse M, Agarwal A, Chan AK, Mondal T. Thrombosis and thromboembolic complications in Fontan patients: a literature review. Clin Appl Thromb Hemost. 2014;20:484-492.
130. Petäjä J, Lundström U, Sairanen H, Marttinen E, Griffin JH. Central venous thrombosis after cardiac operations in children. J Thorac Cardiovasc Surg. 1996;112:883-889.
131. Massicotte M, Chair P. Evidence based recommendation for anticoagulation in children with congenital heart disease (primary prophylaxis: cardiac catheterization, mechanical heart valves, cardiac shunts, central lines and secondary prophylaxis: systemic thrombosis and stroke). Prog Pediatr Cardiol. 2005;21:123-127.
132. Monagle P, Chan A, Goldenberg N, et al. Antithrombotic therapy in neonates and children. Chest. 2012;141(2 suppl):e737S-e801S.
133. Giglia TM, Massicotte MP, Tweddell JS, et al; American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, and Stroke Council. Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2013;128:2622-2703.
134. Mir A, Frank S, Journeycake J, et al. Aspirin resistance in single- ventricle physiology: aspirin prophylaxis is not adequate to inhibit platelets in the immediate postoperative period. Ann Thorac Surg. 2015;99:2158-2164.
135. Emani S, Trainor B, Zurakowski D, et al. Aspirin unresponsiveness predicts thrombosis in high-risk pediatric patients after cardiac surgery. J Thorac Cardiovasc Surg. 2014;148:810-814.
136. Manlhiot C, Gruenwald CE, Holtby HM, et al. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: impact of low antithrombin activity. J Thorac Cardiovasc Surg. 2016;151:444-450.
137. Vincent JL, Baron JF, Reinhart K, et al; ABC (Anemia and Blood Transfusion in Critical Care) Investigators. Anemia and blood transfusion in critically ill patients. JAMA. 2002;288:1499-1507.
138. Chant C, Wilson G, Friedrich JO. Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study. Crit Care. 2006;10:R140.
139. Zimmerman JE, Seneff MG, Sun X, Wagner DP, Knaus WA. Evaluating laboratory usage in the intensive care unit: patient and institutional characteristics that influence frequency of blood sampling. Crit Care Med. 1997;25:737-748.
140. Fowler RA, Berenson M. Blood conservation in the intensive care unit. Crit Care Med. 2003;31:S715-S720.
141. Gleason E, Grossman S, Campbell C. Minimizing diagnostic blood loss in critically ill patients. Am J Crit Care. 1992;1:85-90.
142. Preusser BA, Lash J, Stone KS, Winningham ML, Gonyon D, Nickel JT. Quantifying the minimum discard sample required for accurate arterial blood gases. Nurs Res. 1989;38:276-279.
143. Valentine SL, Bateman ST. Identifying factors to minimize phlebotomy-induced blood loss in the pediatric intensive care unit. Pediatr Crit Care Med. 2012;13:22-27.
144. Liu J, Ji B, Feng Z, et al. The effect of preprocessing stored red blood cells on neonates undergoing corrective cardiac surgery. ASAIO J. 2007;53:680-683.
145. Samnaliev M, Tran CM, Sloan SR, Gasior I, Lightdale JR, Brustowicz RM. Economic evaluation of cell salvage in pediatric surgery. Paediatr Anaesth. 2013;23:1027-1034.
146. Golab HD, Scohy TV, de Jong PL, Takkenberg JJ, Bogers AJ. Intraoperative cell salvage in infants undergoing elective cardiac surgery: a prospective trial. Eur J Cardiothorac Surg. 2008;34:354-359.
147. LiFen Ye, Lin Ru, Yong F, et al. Effects of circuit residual volume salvage reinfusion on the postoperative clinical outcome for pediatric patients undergoing cardiac surgery. Pediatr Cardiol. 2013; 341088-341093.
148. Daane CR, Golab HD, Meeder JH, Wijers MJ, Bogers AJ. Processing and transfusion of residual cardiopulmonary bypass volume: effects on haemostasis, complement activation, postoperative blood loss and transfusion volume. Perfusion. 2003;18:115-121.
149. Cholette JM, Powers KS, Alfieris GM, et al. Transfusion of cell saver salvaged blood in neonates and infants undergoing open heart surgery significantly reduces RBC and coagulant product transfusions and donor exposures: results of a prospective, randomized, clinical trial. Pediatr Crit Care Med. 2013;14:137-147.
150. Meybohm P, Choorapoikayil S, Wessels A, Herrmann E, Zacharowski K, Spahn DR. Washed cell salvage in surgical patients: a review and meta-analysis of prospective randomized trials. Medicine. 2016;95:1-9.
151. Mazine A, Rached-D'Astous S, Ducruet T, Lacroix J, Poirier N; Pediatric Acute Lung Injury and Sepsis Investigators Network. Blood transfusions after pediatric cardiac operations: A North American Multicenter Prospective Study. Ann Thorac Surg. 2015;100:671-677.
152. Bateman ST, Lacroix J, Boven K, et al; Pediatric Acute Lung Injury and Sepsis Investigators Network. Anemia, blood loss, and blood transfusions in North American children in the intensive care unit. Am J Respir Crit Care Med. 2008;178:26-33.
153. Salvin JW, Scheurer MA, Laussen PC, et al. Blood transfusion after pediatric cardiac surgery is associated with prolonged hospital stay. Ann Thorac Surg. 2011;91:204-210.
154. Kneyber MC, Grotenhuis F, Berger RF, Ebels TW, Burgerhof JG, Albers MJ. Transfusion of leukocyte-depleted RBCs is independently associated with increased morbidity after pediatric cardiac surgery. Pediatr Crit Care Med. 2013;14:298-305.
155. Costello JM, Graham DA, Morrow DF, et al. Risk factors for surgical site infection after cardiac surgery in children. Ann Thorac Surg. 2010;89:1833-1841.
156. Székely A, Cserép Z, Sápi E, et al. Risks and predictors of blood transfusion in pediatric patients undergoing open heart operations. Ann Thorac Surg. 2009;87:187-197.
157. Du Pont-Thibodeau G, Harrington K, Lacroix J. Anemia and red blood cell transfusion in critically ill cardiac patients. Ann Intensive Care. 2014;4:16.
158. Lacroix J, Hébert PC, Hutchison JS, et al; TRIPICU Investigators; Canadian Critical Care Trials Group; Pediatric Acute Lung Injury and Sepsis Investigators Network. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007;356:1609-1619.
159. Willems A, Harrington K, Lacroix J, et al; TRIPICU investigators; Canadian Critical Care Trials Group; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Comparison of two red-cell transfusion strategies after pediatric cardiac surgery: a subgroup analysis. Crit Care Med. 2010;38:649-656.
160. de Gast-Bakker DH, de Wilde RB, Hazekamp MG, et al. Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial. Intensive Care Med. 2013;39:2011-2019.
161. Cholette JM, Rubenstein JS, Alfieris GM, Powers KS, Eaton M, Lerner NB. Children with single-ventricle physiology do not benefit from higher hemoglobin levels post cavopulmonary connection: results of a prospective, randomized, controlled trial of a restrictive versus liberal red-cell transfusion strategy. Pediatr Crit Care Med. 2011;12:39-45.
162. Cholette JM, Swartz MF, Rubenstein J, et al. Outcomes using a conservative versus liberal red blood cell transfusion strategy in infants requiring cardiac operation. Ann Thorac Surg. 2017;103:206-214.
163. Murphy DA, Hockings LE, Andrews RK, et al. Extracorporeal membrane oxygenation-hemostatic complications. Transfus Med Rev. 2015;29:90-101.
164. Mazzeffi M, Greenwood J, Tanaka K, et al. Bleeding, transfusion, and mortality on extracorporeal life support: ECLS Working Group on Thrombosis and Hemostasis. Ann Thorac Surg. 2016;101:682-689.
165. Smith A, Hardison D, Bridges B, Pietsch J. Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenation. Perfusion. 2013;28:54-60.
166. Extracorporeal Life Support Organization. ELSO Guidelines. Available at: http://www.elso.org/resources/Guidelines. aspx. Accessed September 21, 2017.
167. Bembea MM, Annich G, Rycus P, Oldenburg G, Berkowitz I, Pronovost P. Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey. Pediatr Crit Care Med. 2014;14:e77.